2016 American Transplant Congress
Clinical Significance of Solitary Pulmonary Nodules in Liver Transplant Recipients with Hepatocellular Carcinoma.
PURPOSE: Currently, there are no guidelines for the management of solitary pulmonary nodules (SPN) in hepatocellular carcinoma (HCC) patients being evaluated for liver transplantation (LT).…2016 American Transplant Congress
African Americans Have Greater Odds of Late Stage Diagnosis of Hepatocellular Carcinoma in Mississippi.
Department of Surgery, University of Mississippi Medical Center, Jackson, MS.
Introduction: Centers for Disease Control Cancer Data show that death rates from HCC exceed expectations from incident rates in Mississippi, therefore we hypothesized that socioeconomic…2016 American Transplant Congress
Elevated Lung Shunt Fraction as an Independent Predictor of Local Disease Progression and Metastasis in Hepatocellular Carcinoma.
Purpose: To establish a relationship between lung shunt fraction (LSF) and local disease progression as well as the development of metastatic disease.Materials and Methods: A…2016 American Transplant Congress
The Impact of Etiology of Liver Disease and Indication for Transplantation on Access to the Liver Transplant Waiting List in the United States.
Background: Only a small fraction of patients with end-stage liver disease (ESLD) is waitlisted for liver transplantation (LT).Methods: Retrospective cohort study of transplant-eligible ESLD patients…2016 American Transplant Congress
3D-FLM (First, Last, Max): A Novel Summative Measure of Hepatocellular Carcinoma (HCC) Tumor Burden Predicts HCC Recurrence After Liver Transplantation (LT).
1Univ. Colorado, Aurora; 2UCSF, San Francisco.
Risk of recurrent HCC post-LT depends on tumor aggressiveness, pre-LT HCC burden and treatment response while waiting for LT. Standard measures of pre-LT HCC burden…2016 American Transplant Congress
Long-Term Outcomes After Pediatric Liver Transplantation for Malignant Liver Tumors: Effects of Era and Age.
Background: Hepatoblastoma (HB), hepatocellular carcinoma (HCC), along with hemangioendothelioma, hemangiosarcoma, and angiosarcoma (HHA) are rare tumors in children that are treated with orthotopic liver transplantation…2016 American Transplant Congress
Transplantation for Hepatocellularcarcinoma Is There a Tumor Size Limit?
Background:The advent of tumor size based criteria (Milan and UCSF) for transplantation of Hepatocellular carcinomas (HCC) has facilitated access of tumor patients to transplantation. Recent…2016 American Transplant Congress
Predictors of Ultrasound Failure to Detect Hepatocellular Carcinoma in Cirrhotic Livers.
University of California, San Francisco, San Francisco, CA.
Background: Current guidelines recommend ultrasound (US) for hepatocellular carcinoma (HCC) surveillance in cirrhotic livers. However, certain patient and disease characteristics may pose a technical challenge…2016 American Transplant Congress
Use of Autotransfusion During Liver Transplantation for Hepatocellular Carcinoma Does Not Increase Recurrence.
Baylor University Medical Center, Dallas, TX.
IntroductionAutotransfusion (AT) is rarely used in liver transplantation of hepatocellular carcinoma (HCC) patients due to the fear of disease transmission. Leukocyte depleting filters (LDF) can…2016 American Transplant Congress
Pre-Transplant Loco-Regional Therapy for Hepatocellular Carcinoma and Post-Transplant Outcomes: A National Study.
1Saint Louis Univ, Saint Louis; 2East Carolina Univ, Greenville.
Currently most transplant centers use loco-regional therapy to bridge liver transplant (LT) candidates with hepatocellular carcinoma (HCC). However, limited data are available to support the…
- « Previous Page
- 1
- …
- 17
- 18
- 19
- 20
- 21
- …
- 23
- Next Page »